The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Dupixent
Australian Public Assessment Report
Device/Product Name
Dupixent
Active ingredients
Dupilumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-01682-1-5
Submission Type
Extension of indications and major variation (new strength)
Decision
Approved